Hemodynamic alterations and results of treatment in patients with gram-negative septic shock.
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D001794:Blood Pressure; D001803:Blood Transfusion; D002302:Cardiac Output; D002496:Central Venous Pressure; D003911:Dextrans / Q000627:therapeutic use; D004231:Diuresis; D004927:Escherichia coli Infections / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006439:Hemodynamics; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000150:complications; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009638:Norepinephrine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000150:complications; D012039:Regional Blood Flow; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy; D012772:Shock, Septic / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology* / Q000628:therapy*; D012867:Skin / Q000098:blood supply; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000627:therapeutic use
D003911:Dextrans; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D000667:Ampicillin; D007545:Isoproterenol; D009638:Norepinephrine; D008775:Methylprednisolone